In a pancancer cohort of patients treated with ICB from the Memorial Sloan Kettering Cancer Centre, BRCA1 was not associated with OS, whereas patients with BRCA2-altered tumours had a longer OS than those with wild-type BRCA2 [92]. This evidence concerns the gene BRCA1 and neoplasm.